- Home
- LSF vs MLSS Comparison
LSF vs MLSS Comparison
Compare LSF & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSF | MLSS |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 23.7M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | LSF | MLSS |
|---|---|---|
| Price | $2.31 | $0.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $1.00 |
| AVG Volume (30 Days) | 118.3K | ★ 3.3M |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,146,862.00 | $8,929,517.00 |
| Revenue This Year | $18.05 | $8.95 |
| Revenue Next Year | $17.53 | $7.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.73 | 0.59 |
| 52 Week Low | $2.18 | $0.28 |
| 52 Week High | $8.99 | $1.39 |
Technical Indicators
Market Signals| Indicator | LSF | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 28.90 | 46.81 |
| Support Level | $2.18 | $0.31 |
| Resistance Level | $2.78 | $0.37 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 27.67 | 74.97 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.